MACROH2A1 and COVID-19: Furthermore, we propose that it may be involved in the pathogenesis of severe COVID-19 via its function in the monocyte lineage and in the innate immune response to SARS-CoV-2, and additionally, that drug discovery targeting MACROH2A1 could be considered.